Abstract
Glutathione S-transferase (GST) was suggested as an important contributor to Alzheimer’s disease (AD). The GSTs polymorphisms have been investigated as candidate genetic risk factors for AD, yet results remained uncertain. Therefore, we performed a meta-analysis to clarify the relationship of GSTs polymorphisms with the occurrence of AD. PubMed, Embase, Cochrane library and Alzgene databases were searched and potential literatures were selected. Pooled analyses and subgroup analyses were conducted, and also publication bias tests and cumulative meta-analysis. This meta-analysis suggested null associations between polymorphisms of GSTM1, GSTT1, GSTM3, GSTP1, GSTO1 and AD risk. GSTs variants may not have an impact on the morbidity of Alzheimer’s disease. Further well designed researches are required to confirm these findings of the current study.
Similar content being viewed by others
References
Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88:640–651
Armstrong RA (2013) What causes Alzheimer’s disease? Folia Neuropathol 51:169–188
Ellis EM (2007) Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther 115:13–24
Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev 2013:316523
Pocernich CB, Butterfield DA (2012) Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta 1822:625–630
Raza H (2011) Dual localization of glutathione S‐transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease. FEBS J
Lovell MA, Xie C, Markesbery WR (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer’s disease. Neurology 51:1562–1566
Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69:155–167
Da Costa LA, Badawi A, El-Sohemy A (2012) Nutrigenetics and modulation of oxidative stress. Ann Nutr Metab 60(Suppl 3):27–36
Wang T (2014) Meta-analysis of PvuII, XbaI variants in ESR1 gene and the risk of Alzheimer’s disease: the regional European difference. Neurosci Lett 574C:41–46
Mullen B, Muellerleile P, Bryant B (2001) Cumulative meta-analysis: a consideration of indicators of sufficiency and stability. Pers Soc Psychol, Rev
Green VJ, Pirmohamed M, Kitteringham NR et al (1995) Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer’s patients with tacrine transaminitis. Br J Clin Pharmacol 39:411–415
Stroombergen MC, Waring RH (1999) Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 18:141–145
Nicholl DJ, Bennett P, Hiller L et al (1999) A study of five candidate genes in Parkinson’s disease and related neurodegenerative disorders. Neurology 53:1415–1421
Bernardini S, Bellincampi L, Ballerini S et al (2005) Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem 51:944–951
Pinhel MAS, Nakazone MA, Cação JC et al (2008) Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer’s disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem Lab Med 46:439–445
Ghosh T, Mustafa M, Kumar V et al (2012) A preliminary study on the influence of glutathione S transferase T1 (GSTT1) as a risk factor for late onset Alzheimer’s disease in North Indian population. Asian J Psychiatr 5:160–163
Piacentini S, Polimanti R, Squitti R et al (2012) GSTM1 null genotype as risk factor for late-onset Alzheimer’s disease in Italian patients. J Neurol Sci 317:137–140
Piacentini S, Polimanti R, Squitti R et al (2012) GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer’s disease: association hypothesis for an uncommon genetic variant. Neurosci Lett 506:203–207
De Sousa M, Pirmohamed M, Kitteringham NR et al (1998) No association between tacrine transaminitis and the glutathione transferase theta genotype in patients with Alzheimer’s disease. Pharmacogenetics 8:353–355
Hong G-S, Heun R, Jessen F et al (2009) Gene variations in GSTM3 are a risk factor for Alzheimer’s disease. Neurobiol Aging 30:691–696
Maes OC, Schipper HM, Chong G et al (2010) A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease. Neurobiol Aging 31:34–45
Bullock JM, Medway C, Cortina-Borja M et al (2013) Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer’s disease. Neurobiol Aging 34(1309):e1–e7
Žuntar I, Kalanj-Bognar S, Topic E et al (2004) The glutathione S-transferase polymorphisms in a control population and in Alzheimer’s disease patients. Clin Chem Lab Med. doi:10.1515/cclm.2004.059
Giedraitis V, Kilander L, Degerman-Gunnarsson M et al (2009) Genetic analysis of Alzheimer’s disease in the Uppsala Longitudinal Study of Adult Men. Dement Geriatr Cogn Disord 27:59–68
Kölsch H, Linnebank M, Lütjohann D et al (2004) Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63:2255–2260
Ozturk A, Desai PP, Minster RL et al (2005) Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer’s disease. Neurobiol Aging 26:1161–1165
Capurso C, Panza F, Seripa D et al (2010) Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease. Rejuvenation Res 13:645–652
Wang T, Wang B (2014) Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson’s disease: a meta-analysis. J Neurol Sci 338:65–70
Singh NK, Banerjee BD, Bala K et al (2014) Polymorphism in cytochrome P450 2D6, glutathione S-transferases Pi 1 genes, and organochlorine pesticides in Alzheimer disease: a case-control study in North Indian population. J Geriatr Psychiatry Neurol 27:119–127
Andrukhova O, Salama M, Rosenhek R et al (2012) Serum glutathione S-transferase P1 1 in prediction of cardiac function. J Card Fail 18:253–261
Allen M, Zou F, Chai HS et al (2012) Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener 7:13
Acknowledgments
The author thanks Xiang Li for his excellent work in article screening and data extraction.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, T. Glutathione S-transferases variants as risk factors in Alzheimer’s disease. Neurol Sci 36, 1785–1792 (2015). https://doi.org/10.1007/s10072-015-2245-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2245-7